Mirae Asset Global Investments Co., Ltd. Repligen Corp Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Repligen Corp stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 12,716 shares of RGEN stock, worth $1.59 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,716
Previous 1,281
892.66%
Holding current value
$1.59 Million
Previous $161,000
1075.16%
% of portfolio
0.01%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RGEN
# of Institutions
487Shares Held
54.4MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$944 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$797 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$629 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$203 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$177 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $6.92B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....